PRNewswire

The acquisition—alongside the addition of Andreessen Horowitz as a shareholder—accelerates ComplyAdvantage's AI capabilities and solidifies its position as one of the industry-leading providers of financial crime insights

NEW YORK, April 24, 2024 /PRNewswire/ -- ComplyAdvantage, a leader in financial crime intelligence, today announced its acquisition of Golden (Golden Recursion Inc). Golden is a San Francisco-based innovator automating the construction of one of... (continue reading...)

8.17% Copper, 69.14 g/t Silver, 8.44 g/t Platinium & 6.25 g/t Palladium,

0.57 g/t Gold & 0.58% Nickel over 14.42 m Highlight Successful Week!

TORONTO, April 24, 2024 /PRNewswire/ - Power Nickel Inc. (the "Company" or "Power Nickel") (OTCBB: PNPNF) (TSXV: PNPN) (Frankfurt: IVV) is pleased to announce it has completed the acquisition of an additional 30% of the Nisk Project from Critical Elements Lithium. The last remaining condition was the acceptance of the filing... (continue reading...)

NORWALK, Conn., April 24, 2024 /PRNewswire/ -- GameChange Solar, a leading global supplier of solar tracking solutions for ground-mounted PV plants, has been selected to supply its Genius Tracker™ solar trackers for four new solar projects totalling over 500 megawatts (MW) in Southern Africa. These projects are strategically positioned to enhance energy supply across the region, supporting the diversification of the energy mix to help ensure a stable electricity... (continue reading...)

LEXINGTON, Ky., April 24, 2024 /PRNewswire/ -- eCampus.com, a leading provider of online bookstore and campus retail solutions, announced today its expanded partnership with Miami University, becoming the official e-commerce merchandise partner for Miami University's Athletics and Alumni Association. This collaboration builds upon the success of eCampus.com's operation of Brick & Ivy, Miami University's Campus Store, which has been under their management since 2021. ... (continue reading...)

• V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investors Oncode Oncology Bridge Fund, Swanbridge and BOM
• Flindr discovers and develops precision oncology therapeutics with the potential to eradicate tumors in specific patient populations
• Lead asset is a first-in-class small molecule inhibitor of the cancer driver RNF31

OSS, Netherlands, April 24,... (continue reading...)